OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group Study

HTML

Year: 1990
Type: article
Study design: Clinical Trial
Source: JNCI Journal of the National Cancer Institute
DOI: 10.1093/jnci/82.2.143
Authors: R. M. Bukowski, P. Goodman, E. D. Crawford, J. S. Sergi, B. G. Redman, R. P. Whitehead
Institutions: Cleveland Clinic, SWOG Cancer Research Network, University of Colorado Denver, Wayne State University, University of New Mexico
Language: English

Topic: Renal cell carcinoma treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: metastatic renal cell carcinoma, interleukin-2, high-dose interleukin-2, intermittent dosing, indomethacin, drug toxicity, hypotension, myelosuppression, tumor response, complete response, outpatient administration, Southwest Oncology Group
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: Southwest Oncology Group, University of Colorado Southwest Oncology Group, SWOG Community Clinical Oncology Program Research Base
OpenAlex ID: W2138463196
FWCI: 7.769
Cites:
Cited by: 105
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security